Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (OTC:AIRDF) entered a one-year investor relations and marketing agreement with North Star Investor Relations, effective May 15, 2026, subject to regulatory approval.
North Star will receive C$10,000 per month, no shares, options, or performance factors, and currently holds no interest in the company.
Rocket Doctor AI (OTC:AIRDF) and the University of Toronto launched a digital health observership program for first-year Physician Assistant students. The first clinic began on April 14, 2026, using Rocket Doctor’s virtual and hybrid platform.
Students rotate across multiple clinics, observing Physician Assistants and, when available, physicians, gaining exposure to diverse providers, workflows, and patient scenarios while learning technology-enabled care models.
Rocket Doctor AI (OTC: AIRDF) reported audited FY2025 results showing annual revenue of $1,739,219, Q4 2025 revenue of $697,340 (31.8% QoQ growth from Q3), and Q4 EPS of ($0.10). Gross margin for Q4 was 84% and Adjusted EBITDA was a $2.1M loss. The company closed key U.S. in-network payer agreements expanding reach to over 21 million covered lives, received >$500k of an NIH SBIR award, completed the Alea Health acquisition, and raised ~$5.2M in January 2026.
Rocket Doctor Inc. (OTC: AIRDF) was selected to join the Canadian Life Sciences Trade Mission to New York and New Jersey, May 11–14, 2026. Founder and CEO Dr. William Cherniak will deliver a featured two-minute pitch at the Canadian Consulate and meet U.S. investors and partners.
The mission offers access to the New York/New Jersey life sciences corridor, outreach to investors and healthcare leaders, and curated meetings including NYCEDC programming and innovation-hub visits.
Rocket Doctor (OTC: AIRDF) expanded its Maryland in-network reach by ~250,000 additional members, bringing total covered lives in the state to ~3.2 million.
Effective April 27, 2026, the recurring 12-month agreement with a major national payer covers Commercial and Medicare Advantage lines, enabling in-network access to primary care, chronic disease management, preventive services and virtual urgent care, subject to plan eligibility and credentialing.
The deal aligns with Maryland’s 2026 AHEAD model and aims to improve access, continuity of physician-led care, and reduce unnecessary emergency department use.
Rocket Doctor AI (OTC:AIRDF) entered a 30-day addendum with 45 Degrees to run a specialized media services campaign focused on ramping up Google Advertising.
Key terms: a one-time payment of USD $17,000 payable on signing, no equity or options, and no performance-based fees; subject to regulatory approval.
Rocket Doctor AI (OTC:AIRDF) secured an in-network agreement with the Maryland state entity of a major national insurer, adding approximately 2 million members and bringing total in-network reach to about 21 million members nationwide.
The agreement covers commercial, Medicaid managed care and Medicare Advantage plans, is a recurring 12-month term commencing Feb 19, 2026, and includes a 90-day mutual termination clause. Eligible members gain access to board-certified physicians via Rocket Doctor’s digital primary care and virtual services, subject to plan eligibility and credentialing.
Rocket Doctor AI (OTC:AIRDF) launched patient care operations in Maryland after securing in-network coverage with Medicaid and Medicare and has appointed Dr. Suzanne Caccamese as Maryland Medical Lead.
The company’s digital health platform is now delivering care via board-certified, in-state physicians as part of its U.S. expansion into underserved, high-demand markets.
Rocket Doctor (OTC: AIRDF) appointed Dr. Anikia Nelson as Director of Product and Bilal Malik as Director of Engineering to advance its digital health platform and AI capabilities. The company granted 143,388 RSUs and 5,738 options at C$0.70 exercise price, each with three-year terms and vesting provisions.
Appointments target product roadmap, scalability, interoperability, HIPAA-compliant infrastructure, and growth across North America.
Rocket Doctor AI (OTC:AIRDF) announced a new in-network agreement with a major California health plan, adding approximately 330,000 Medicare Advantage members and more than 1.7 million commercial members across California, expanding in-network access by ~2.03 million members.
Eligible members gain access to Rocket Doctor’s board-certified physicians for primary care, chronic disease management, preventive services and coordinated follow-up via its digital health platform, subject to credentialing and plan eligibility.